Home › Eierstokkanker › Louisiana › New Orleans
Eierstokkanker klinische studies in New Orleans, LA
12 studies voor Eierstokkanker zoeken deelnemers op locaties in en rond New Orleans (binnen ongeveer 30 mijl). Open een studie om te zien wie er kan deelnemen en hoe je contact opneemt met het studieteam.
Officiële studietekst (Engels)
Rekruteren voor een studie? Laat deze bovenaan deze pagina verschijnen — $99 voor 30 dagen →
Phase 3 Trial Evaluating the Safety & Efficacy of IMNN-001 Administered in Combination w/ Standard NACT & Adjuvant Chemotherapy in Newly Diagnosed Patients w/ Advanced EOC, Fallopian Tube or Primary Peritoneal Cancer
RekruterenFase 3
- Louisiana State University HSC - NO Cancer Center, New Orleans
Testing the Addition of Paclitaxel Administered Into the Abdominal Cavity Combined With Chemotherapy for Patients With Gastric Cancer Spread to the Abdominal Cavity
RekruterenFase 2/3
- University Medical Center New Orleans, New Orleans
Targeted Therapy Directed by Genetic Testing in Treating Patients With Locally Advanced or Advanced Solid Tumors, The ComboMATCH Screening Trial
RekruterenFase 2
- Ochsner Medical Center Jefferson, New Orleans
Leveraging Methylated DNA Markers (MDMs) in the Detection of Endometrial Cancer, Ovarian Cancer, and Cervical Cancer
RekruterenObservatieonderzoek
- Ochsner Clinic Foundation, New Orleans
A Study to Assess Anti-Tumor Activity of Intravenously (IV) Infused Carboplatin With Mirvetuximab Soravtansine in Participants With Newly Diagnosed Folate Receptor Alpha (FRα)Expressing Advanced-Stage Serous Epithelial Ovarian, Fallopian Tube or Primary Peritoneal Cancer.
RekruterenFase 2
- University Medical Center New Orleans /ID# 274755, New Orleans
A Three-Part Phase 3 Study of Sofetabart Mipitecan in Participants With Platinum-Resistant (Part A) and Platinum-Sensitive (Parts B and C) Ovarian Cancer
RekruterenFase 3
- Ochsner Clinic Foundation, New Orleans
ORACLE: Observation of ResiduAl Cancer With Liquid Biopsy Evaluation
RekruterenObservatieonderzoek
- Tulane Cancer Center, New Orleans
A Study to Compare Two Surgical Procedures in Individuals With BRCA1 Mutations to Assess Reduced Risk of Ovarian Cancer
Rekruteren
- Louisiana State University Health Science Center, New Orleans
- University Medical Center New Orleans, New Orleans
- West Jefferson Medical Center, Marrero · 4 mijl verwijderd
Testing Olaparib for One or Two Years, With or Without Bevacizumab, to Treat Ovarian Cancer
RekruterenFase 3
- University Medical Center New Orleans, New Orleans
- Ochsner Baptist Medical Center, New Orleans
- Ochsner Medical Center Jefferson, New Orleans
- en nog 1
First-in-Human Study of Tersolisib (STX-478) as Monotherapy and in Combination With Other Antineoplastic Agents in Participants With Advanced Solid Tumors
RekruterenFase 1/2
- Louisiana State University Health Sciences Center, New Orleans
Heated Intraperitoneal Chemotherapy Followed by Niraparib for Ovarian, Primary Peritoneal and Fallopian Tube Cancer
RekruterenFase 3
- LSU Health New Orleans, New Orleans
- University Medical Center New Orleans, New Orleans
SYNERGY-AI: Artificial Intelligence Based Precision Oncology Clinical Trial Matching and Registry
RekruterenObservatieonderzoek
- Massive Bio SYNERGY-AI site, New Orleans
Eierstokkanker studies in andere steden
- Houston, TX89 studies
- New York City, NY69 studies
- Boston, MA61 studies
- Los Angeles, CA50 studies
- Nashville, TN49 studies
- Arlington, VA46 studies
- Philadelphia, PA44 studies
- Columbus, OH39 studies
- St. Louis, MO38 studies
- Chicago, IL36 studies
- San Antonio, TX31 studies
- Cleveland, OH30 studies
Andere studies in New Orleans
- Kanker (alle vormen)12 studies
- Borstkanker11 studies
- Prostaatkanker10 studies
- Endometriumkanker9 studies
- Metastatische kanker9 studies
- Longkanker9 studies
- Niet-kleincellige longkanker9 studies
- Cardiovasculaire ziekte9 studies
- Obesitas8 studies
- Steatotische leveraandoening8 studies
- Colorectale kanker8 studies
- Atriumfibrilleren8 studies
Van ClinicalTrials.gov, gegevens opgehaald op 6 okt. 2026. Elke studie stelt eigen deelnamecriteria vast; het studieteam bepaalt wie er kan deelnemen.